{"id":5935,"date":"2024-03-21T16:28:00","date_gmt":"2024-03-21T16:28:00","guid":{"rendered":"https:\/\/gevers.expliciet.dev\/?p=5935"},"modified":"2026-03-17T09:06:25","modified_gmt":"2026-03-17T09:06:25","slug":"ia-biotech","status":"publish","type":"post","link":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/","title":{"rendered":"L\u2019intelligence artificielle dans le domaine des biotechnologies"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">L\u2019intelligence artificielle (IA) est aujourd\u2019hui appliqu\u00e9e dans presque tous les domaines technologiques. Le domaine des biotechnologies ne fait pas exception \u00e0 la r\u00e8gle. Dans de nombreuses innovations BioTech, l\u2019IA est impliqu\u00e9e et absorbe une grande partie des investissements. Pour obtenir un retour sur investissement fiable, il est indispensable d\u2019adopter une approche proactive en ce qui concerne la protection de ces innovations.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Comment prot\u00e9ger vos innovations en mati\u00e8re d\u2019IA ?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Compte tenu de l\u2019impact croissant de l\u2019IA sur les d\u00e9veloppements biotechnologiques, il est n\u00e9cessaire de mettre en place une strat\u00e9gie de propri\u00e9t\u00e9 intellectuelle qui tienne compte des sp\u00e9cificit\u00e9s de l\u2019IA. Cette strat\u00e9gie devrait pr\u00e9voir une protection appropri\u00e9e des algorithmes d\u2019IA, des donn\u00e9es trait\u00e9es, ainsi que des produits d\u00e9velopp\u00e9s \u00e0 l\u2019aide des algorithmes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Avec l\u2019introduction de l\u2019IA, l\u2019accent est mis non plus sur la recherche fondamentale, mais sur le d\u00e9veloppement de r\u00e9seaux neuronaux. Cela offre aux entreprises de biotechnologie de nouvelles opportunit\u00e9s qui posent des d\u00e9fis en raison de leur manque de familiarit\u00e9, \u00e0 savoir le domaine des inventions mises en \u0153uvre par ordinateur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019une des premi\u00e8res questions que se pose une entreprise qui se lance dans l\u2019IA est la suivante : \u00ab&nbsp;<strong>L\u2019IA est-elle brevetable ?<\/strong>\u00ab&nbsp;. Il s\u2019agit d\u2019une question cruciale lors de l\u2019\u00e9laboration de la strat\u00e9gie de propri\u00e9t\u00e9 intellectuelle. La r\u00e9ponse est heureusement \u00ab&nbsp;oui&nbsp;\u00bb, bien qu\u2019elle soit assortie de conditions. Si l\u2019IA contribue \u00e0 la r\u00e9alisation d\u2019un objectif technique, elle est prise en compte pour l\u2019\u00e9valuation de l\u2019\u00e9vidence. En pratique, cela signifie que si l\u2019invention implique, par exemple, un r\u00e9seau neuronal pour accomplir une certaine t\u00e2che, l\u2019Office europ\u00e9en des brevets (OEB) doit \u00e9valuer si la t\u00e2che accomplie est technique.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dans un sch\u00e9ma :<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter is-resized\"><img decoding=\"async\" src=\"https:\/\/anais.gevers.eu\/wp-content\/uploads\/2024\/03\/Image1-320x42.png\" alt=\"\" class=\"wp-image-17906\" style=\"width:680px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Lorsqu\u2019un ensemble de donn\u00e9es est utilis\u00e9 dans un r\u00e9seau neuronal, avec d\u2019autres caract\u00e9ristiques, pour accomplir une t\u00e2che telle qu\u2019illustr\u00e9e dans le sch\u00e9ma, la question automatique qui doit \u00eatre soulev\u00e9e est la suivante : \u00ab&nbsp;La t\u00e2che a-t-elle une finalit\u00e9 technique ?&nbsp;\u00bb. Si la r\u00e9ponse est positive, le r\u00e9seau neuronal est alors pris en consid\u00e9ration pour l\u2019\u00e9valuation de l\u2019\u00e9vidence (activit\u00e9 inventive). Si la r\u00e9ponse est n\u00e9gative, le r\u00e9seau neuronal n\u2019est pas pris en compte.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lorsque l\u2019on utilise l\u2019IA, on cr\u00e9e g\u00e9n\u00e9ralement un ensemble de donn\u00e9es d\u2019entra\u00eenement sp\u00e9cifiques. La prochaine question qui se pose dans le cadre de la strat\u00e9gie de propri\u00e9t\u00e9 intellectuelle pour les inventions d\u2019IA est donc la suivante : \u00ab&nbsp;<strong>L\u2019ensemble de donn\u00e9es d\u2019entra\u00eenement peut-il \u00eatre prot\u00e9g\u00e9&nbsp;<\/strong>? Cet aspect offre \u00e9galement des possibilit\u00e9s de cr\u00e9er une protection par brevet. Si la formation permet d\u2019atteindre l\u2019objectif technique, l\u2019ensemble de donn\u00e9es de formation peut \u00eatre prot\u00e9g\u00e9.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L\u2019ensemble des donn\u00e9es de formation est un aspect, mais qu\u2019en est-il des \u00e9tapes de la phase de formation ? Ici aussi, si les \u00e9tapes de la phase de formation soutiennent l\u2019objectif technique, les \u00e9tapes de la phase de formation peuvent \u00e9galement \u00eatre prot\u00e9g\u00e9es.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">D\u2019apr\u00e8s ce qui pr\u00e9c\u00e8de, il est important de comprendre les aspects techniques pour d\u00e9terminer les possibilit\u00e9s de protection par brevet. C\u2019est pourquoi plusieurs exemples de ce qui est \u00ab&nbsp;technique&nbsp;\u00bb sont pr\u00e9sent\u00e9s ci-dessous \u00e0 titre de r\u00e9f\u00e9rence :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>l\u2019am\u00e9lioration ou l\u2019analyse de l\u2019audio, de l\u2019image ou de la vid\u00e9o num\u00e9riques, par exemple l\u2019analyse d\u2019images m\u00e9dicales ;<\/li>\n\n\n\n<li>fournir une estimation du g\u00e9notype sur la base d\u2019une analyse des \u00e9chantillons d\u2019ADN, ainsi qu\u2019un intervalle de confiance pour cette estimation afin d\u2019en quantifier la fiabilit\u00e9 ;<\/li>\n\n\n\n<li>d\u00e9duire la temp\u00e9rature corporelle d\u2019un sujet \u00e0 partir des donn\u00e9es obtenues par un d\u00e9tecteur de temp\u00e9rature auriculaire ;<\/li>\n\n\n\n<li>la compression de donn\u00e9es audio, d\u2019images, de vid\u00e9os ou de capteurs ;<\/li>\n\n\n\n<li>le codage des donn\u00e9es ;<\/li>\n\n\n\n<li>d\u00e9terminer la d\u00e9pense \u00e9nerg\u00e9tique d\u2019un sujet en traitant les donn\u00e9es obtenues \u00e0 partir de capteurs physiologiques ;<\/li>\n\n\n\n<li>l\u2019\u00e9tablissement d\u2019un diagnostic m\u00e9dical par un syst\u00e8me automatis\u00e9 de traitement des mesures physiologiques ;<\/li>\n\n\n\n<li>pr\u00e9dire l\u2019affinit\u00e9 de liaison d\u2019une mol\u00e9cule \u00e0 une prot\u00e9ine cible.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Une recherche portant sur les publications de brevets relatives \u00e0 des inventions d\u2019IA dans le domaine des biotechnologies illustre l\u2019importance croissante de l\u2019IA au cours des cinq derni\u00e8res ann\u00e9es.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter is-resized\"><img decoding=\"async\" src=\"https:\/\/anais.gevers.eu\/wp-content\/uploads\/2024\/03\/Image2-320x145.png\" alt=\"\" class=\"wp-image-17910\" style=\"width:554px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">L\u2019augmentation des publications de brevets a commenc\u00e9 en 2016 et se poursuit. Cette acc\u00e9l\u00e9ration devrait se poursuivre dans les ann\u00e9es \u00e0 venir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le brevet EP2550529 est un exemple typique de brevet d\u00e9livr\u00e9 utilisant l\u2019IA dans le domaine de la biotechnologie. Ce brevet porte sur l\u2019identification de ligands. Au cours de la proc\u00e9dure, l\u2019OEB confirme que l\u2019identification des ligands implique un objectif technique, ce qui fait que les caract\u00e9ristiques non techniques contribuant \u00e0 l\u2019identification des ligands sont prises en compte pour l\u2019\u00e9valuation de l\u2019\u00e9vidence (activit\u00e9 inventive).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En conclusion, maintenant que l\u2019IA est entr\u00e9e de plain-pied dans le domaine des biotechnologies, il est plus strat\u00e9gique et utile que jamais de disposer d\u2019une strat\u00e9gie de propri\u00e9t\u00e9 intellectuelle bien pens\u00e9e qui prenne en compte les possibilit\u00e9s de sp\u00e9cificit\u00e9 des inventions mises en \u0153uvre par ordinateur.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019intelligence artificielle (IA) est aujourd\u2019hui appliqu\u00e9e dans presque tous les domaines technologiques. Le domaine des biotechnologies ne fait pas exception \u00e0 la r\u00e8gle. Dans de nombreuses innovations BioTech, l\u2019IA est impliqu\u00e9e et absorbe une grande partie des investissements. Pour obtenir un retour sur investissement fiable, il est indispensable d\u2019adopter une approche proactive en ce qui [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":5936,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","sync_status":"","episode_type":"","audio_file":"","podmotor_file_id":"","podmotor_episode_id":"","castos_file_data":"","cover_image":"","cover_image_id":"","duration":"","filesize":"","filesize_raw":"","date_recorded":"","explicit":"","block":"","_ayudawp_aiss_exclude":false,"_ayudawp_aiss_exclude_summary":false,"_ayudawp_aiss_summary":"","_ayudawp_aiss_summary_provider":"","_ayudawp_aiss_summary_hash":"","footnotes":""},"categories":[214],"tags":[],"expertises":[162],"class_list":["post-5935","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications-fr","expertises-brevets"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.5 (Yoast SEO v28.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>IA et biotechnologies : prot\u00e9ger l\u2019innovation | Gevers<\/title>\n<meta name=\"description\" content=\"S\u00e9curisez vos innovations et vos investissements gr\u00e2ce \u00e0 une strat\u00e9gie de protection en propri\u00e9t\u00e9 intellectuelle adapt\u00e9e.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019intelligence artificielle dans le domaine des biotechnologies\" \/>\n<meta property=\"og:description\" content=\"S\u00e9curisez vos innovations et vos investissements gr\u00e2ce \u00e0 une strat\u00e9gie de protection en propri\u00e9t\u00e9 intellectuelle adapt\u00e9e.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Gevers\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-21T16:28:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-17T09:06:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/08\/AdobeStock_726001901-1536x861-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"861\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frank Van Coppenolle\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gevers Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/\"},\"author\":{\"name\":\"Frank Van Coppenolle\",\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#\\\/schema\\\/person\\\/b924e34c4af4aa52e96bd9058b7c2eb2\"},\"headline\":\"L\u2019intelligence artificielle dans le domaine des biotechnologies\",\"datePublished\":\"2024-03-21T16:28:00+00:00\",\"dateModified\":\"2026-03-17T09:06:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/\"},\"wordCount\":952,\"publisher\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/gevers.eu\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/AdobeStock_726001901-1536x861-1.jpeg\",\"articleSection\":[\"Publications\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/\",\"url\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/\",\"name\":\"IA et biotechnologies : prot\u00e9ger l\u2019innovation | Gevers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/gevers.eu\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/AdobeStock_726001901-1536x861-1.jpeg\",\"datePublished\":\"2024-03-21T16:28:00+00:00\",\"dateModified\":\"2026-03-17T09:06:25+00:00\",\"description\":\"S\u00e9curisez vos innovations et vos investissements gr\u00e2ce \u00e0 une strat\u00e9gie de protection en propri\u00e9t\u00e9 intellectuelle adapt\u00e9e.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/blog\\\/ia-biotech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/gevers.eu\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/AdobeStock_726001901-1536x861-1.jpeg\",\"contentUrl\":\"https:\\\/\\\/gevers.eu\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/AdobeStock_726001901-1536x861-1.jpeg\",\"width\":1536,\"height\":861},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/\",\"name\":\"Gevers\",\"description\":\"Empowering Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#organization\",\"name\":\"Gevers\",\"url\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/gevers.eu\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/GEVERS-LOGO.svg\",\"contentUrl\":\"https:\\\/\\\/gevers.eu\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/GEVERS-LOGO.svg\",\"width\":1,\"height\":1,\"caption\":\"Gevers\"},\"image\":{\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/gevers.eu\\\/fr\\\/#\\\/schema\\\/person\\\/b924e34c4af4aa52e96bd9058b7c2eb2\",\"name\":\"Frank Van Coppenolle\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/gevers.local\\\/#\\\/schema\\\/person\\\/image\\\/\",\"url\":\"https:\\\/\\\/gevers.eu\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Frank-Van-Coppenolle-2025-800x800-1-200x200.jpg\",\"contentUrl\":\"https:\\\/\\\/gevers.eu\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Frank-Van-Coppenolle-2025-800x800-1-200x200.jpg\",\"caption\":\"Frank Van Coppenolle\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"IA et biotechnologies : prot\u00e9ger l\u2019innovation | Gevers","description":"S\u00e9curisez vos innovations et vos investissements gr\u00e2ce \u00e0 une strat\u00e9gie de protection en propri\u00e9t\u00e9 intellectuelle adapt\u00e9e.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019intelligence artificielle dans le domaine des biotechnologies","og_description":"S\u00e9curisez vos innovations et vos investissements gr\u00e2ce \u00e0 une strat\u00e9gie de protection en propri\u00e9t\u00e9 intellectuelle adapt\u00e9e.","og_url":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/","og_site_name":"Gevers","article_published_time":"2024-03-21T16:28:00+00:00","article_modified_time":"2026-03-17T09:06:25+00:00","og_image":[{"width":1536,"height":861,"url":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/08\/AdobeStock_726001901-1536x861-1.jpeg","type":"image\/jpeg"}],"author":"Frank Van Coppenolle","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gevers Editor","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/#article","isPartOf":{"@id":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/"},"author":{"name":"Frank Van Coppenolle","@id":"https:\/\/gevers.eu\/fr\/#\/schema\/person\/b924e34c4af4aa52e96bd9058b7c2eb2"},"headline":"L\u2019intelligence artificielle dans le domaine des biotechnologies","datePublished":"2024-03-21T16:28:00+00:00","dateModified":"2026-03-17T09:06:25+00:00","mainEntityOfPage":{"@id":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/"},"wordCount":952,"publisher":{"@id":"https:\/\/gevers.eu\/fr\/#organization"},"image":{"@id":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/08\/AdobeStock_726001901-1536x861-1.jpeg","articleSection":["Publications"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/","url":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/","name":"IA et biotechnologies : prot\u00e9ger l\u2019innovation | Gevers","isPartOf":{"@id":"https:\/\/gevers.eu\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/#primaryimage"},"image":{"@id":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/08\/AdobeStock_726001901-1536x861-1.jpeg","datePublished":"2024-03-21T16:28:00+00:00","dateModified":"2026-03-17T09:06:25+00:00","description":"S\u00e9curisez vos innovations et vos investissements gr\u00e2ce \u00e0 une strat\u00e9gie de protection en propri\u00e9t\u00e9 intellectuelle adapt\u00e9e.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/gevers.eu\/fr\/blog\/ia-biotech\/#primaryimage","url":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/08\/AdobeStock_726001901-1536x861-1.jpeg","contentUrl":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/08\/AdobeStock_726001901-1536x861-1.jpeg","width":1536,"height":861},{"@type":"WebSite","@id":"https:\/\/gevers.eu\/fr\/#website","url":"https:\/\/gevers.eu\/fr\/","name":"Gevers","description":"Empowering Innovation","publisher":{"@id":"https:\/\/gevers.eu\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gevers.eu\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/gevers.eu\/fr\/#organization","name":"Gevers","url":"https:\/\/gevers.eu\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/gevers.eu\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/04\/GEVERS-LOGO.svg","contentUrl":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/04\/GEVERS-LOGO.svg","width":1,"height":1,"caption":"Gevers"},"image":{"@id":"https:\/\/gevers.eu\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/gevers.eu\/fr\/#\/schema\/person\/b924e34c4af4aa52e96bd9058b7c2eb2","name":"Frank Van Coppenolle","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/gevers.local\/#\/schema\/person\/image\/","url":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/04\/Frank-Van-Coppenolle-2025-800x800-1-200x200.jpg","contentUrl":"https:\/\/gevers.eu\/wp-content\/uploads\/2024\/04\/Frank-Van-Coppenolle-2025-800x800-1-200x200.jpg","caption":"Frank Van Coppenolle"}}]}},"_links":{"self":[{"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/posts\/5935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/comments?post=5935"}],"version-history":[{"count":0,"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/posts\/5935\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/media\/5936"}],"wp:attachment":[{"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/media?parent=5935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/categories?post=5935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/tags?post=5935"},{"taxonomy":"expertises","embeddable":true,"href":"https:\/\/gevers.eu\/fr\/wp-json\/wp\/v2\/expertises?post=5935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}